(R)-tert-butyl 2-(2-(benzyloxycarbonylamino)-2-phenylacetamido)acetate 100mg
-
Catalog numberCS-M0750-100mg
-
PricePlease ask
-
Size100mg
-
-
Alternative_NamesNA
-
CAS439088-73-0
-
Purity>98%
-
MWt398.45
-
FormulaC22H26N2O5
-
SolubilityNA
-
MDLNA
-
SMILESO=C(OCC1=CC=CC=C1)N[C@H](C2=CC=CC=C2)C(NCC(OC(C)(C)C)=O)=O
-
Gene target
-
Short name(R)-tert-butyl 2-(2-(benzyloxycarbonylamino)-2-phenylacetamido)acetate 100mg
-
Alternative name(R)-telomerase reverse transcriptase-butyl 2-(2-(benzyloxycarbonylamino)-2-phenylacetamido)acetate 100mg
-
Alternative to gene targettelomerase reverse transcriptase, CMM9 and DKCA2 and DKCB4 and EST2 and hEST2 and hTRT and PFBMFT1 and TCS1 and TP2 and TRT, TERT and IDBG-10998 and ENSG00000164362 and 7015, telomeric RNA binding, nuclei, Tert and IDBG-165912 and ENSMUSG00000021611 and 21752, BT.60929 and IDBG-632169 and ENSBTAG00000012567 and 518884
-
MeSH Data
-
Name
-
ConceptScope note: The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
-
Tree numbers
- E05.393.220
-
Qualifiersdrug effects, methods, radiation effects